PROVIDER PROFILE · NPI 1548219413

Mouhammed HabraM.D.

PRACTICEMDACCSee all providers at this practice →

EndocrinologyHouston, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

244

Unique beneficiaries

—

Total services

284

Distinct HCPCS

Medicare payment

$20K

Peer benchmark

Total Medicare services vs. 484 Endocrinology providers in TX — bottom quintile (cohort median 868).

PRESCRIBING · PART D · 2024

Total Rx claims

387

Beneficiaries

—

Total drug cost

$1.7M

Distinct drugs

Brand share

33.1%

Top prescribed drugs

Levothyroxine Sodium170 claims

Hydrocortisone34 claims

Levothyroxine Sodium32 claims

Lenvatinib Mesylate32 claims

Dabrafenib Mesylate28 claims

QUALITY · MIPS · 2024

Final MIPS score

84.3

Quality

70.8

Cost

67.6

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.39%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$4K

Payment records

By payment type

Consulting Fee$4K

REFERRAL NETWORK

Where Mouhammed Habra's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER	155	482
NPI 1245335710	19	30

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history